IP Library Assignment 047724/0470
Patent Assignment
Reel/Frame 047724/0470

Assignment of Assignor's Interest

Recorded: 2018-12-05 Pages: 33
Assignor
MAY, BRUCE CHANDLER
Executed: 2018-11-05
Assignee
IRR, INC.
515 E. MICHELTORENA ST., STE. G, SANTA BARBARA, CALIFORNIA, 93103
Covered Properties (19)
Use of Levocetirizine and Montelukast in the Treatment of Influenza, Common Cold and Inflammation
Patent: 9,044,479 →
Application: 13/704,589 →
Publication: US 2013/0085124
Use of Levocetirizine and Montelukast in the Treatment of Vasculitis
Patent: 9,669,025 →
Application: 14/831,100 →
Publication: US 2015/0352101
Use of Levocetirizine and Montelukast in the Treatment of Anaphylaxis
Application: 14/831,213 →
Publication: US 2015/0352102
Use of Levocetirizine and Montelukast in the Treatment of Autoimmune Disorders
Patent: 9,669,026 →
Application: 14/831,339 →
Publication: US 2015/0352103
Use of Levocetirizine and Montelukast in the Treatment of Traumatic Injury
Patent: 9,522,148 →
Application: 14/831,469 →
Publication: US 2015/0352104
Use of Levocetirizine and Montelukast to Ameliorate Inflammation Following Radiation Exposure
Application: 14/974,930 →
Publication: US 2016/0175301
Use of Levocetirizine and Montelukast in the Treatment of Traumatic Injury
Patent: 9,937,166 →
Application: 15/348,253 →
Publication: US 2017/0056395
Levocetirizine and Montelukast in the Treatment of Inflammation Mediated Conditions
Patent: 9,925,183 →
Application: 15/450,840 →
Publication: US 2017/0173001
Use of Levocetirizine and Montelukast in the Treatment of Vasculitis
Application: 15/584,499 →
Publication: US 2017/0231980
Use of Levocetirizine and Montelukast in the Treatment of Autoimmune Disorders
Application: 15/584,795 →
Publication: US 2017/0296534
Use of Levocetirizine and Montelukast in the Treatment of Anaphylaxis
Application: 15/649,180 →
Publication: US 2017/0368059
Levocetirizine and Montelukast in the Treatment of Inflammation Mediated Conditions
Application: 15/895,918 →
Publication: US 2018/0169091
Use of Levocetirizine and Montelukast in the Treatment of Traumatic Injury
Application: 15/908,387 →
Publication: US 2018/0185357
Use of Levocetirizine and Montelukast in the Treatment of Influenza, Common Cold and Associated Acute Inflammation
Application: 61/355,520 →
Use of Levocetirizine and Montelukast in the Treatment of Acute Lung and Brain Injury
Application: 61/780,336 →
Use of Levocetirizine and Montelukast in the Treatment of Vasculitis
Application: 61/780,380 →
Use of Levocetirizine and Montelukast in the Treatment of Autoimmune Disorders
Application: 61/780,420 →
Use of Levocetirizine and Montelukast in the Treatment of Anaphylaxis
Application: 61/780,452 →
Levocetirizine and Montelukast in the Treatment of Nf-Kb Mediated Conditions
Application: 62/050,668 →
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 10, 2013
From: MAY, BRUCE CHANDLER
To: INFLAMMATORY RESPONSE RESEARCH, INC.
Reel/Frame 031175/0104 →
Assignment of Assignor's Interest Sep 10, 2013
From: MAY, BRUCE CHANDLER
To: INFLAMMATORY RESPONSE RESEARCH
Reel/Frame 031175/0256 →
Assignment of Assignor's Interest Sep 10, 2013
From: MAY, BRUCE CHANDLER
To: INFLAMMATORY RESPONSE RESEARCH, INC.
Reel/Frame 031175/0196 →
Assignment of Assignor's Interest Sep 10, 2013
From: MAY, BRUCE CHANDLER
To: INFLAMMATORY RESPONSE RESEARCH, INC.
Reel/Frame 031175/0127 →
Assignment of Assignor's Interest Jun 10, 2015
From: MAY, BRUCE CHANDLER
To: INFLAMMATORY RESPONSE RESEARCH, INC.
Reel/Frame 035818/0409 →
Assignment of Assignor's Interest Sep 3, 2015
From: MAY, BRUCE CHANDLER
To: INFLAMMATORY RESPONSE RESEARCH, INC.
Reel/Frame 036488/0911 →
Assignment of Assignor's Interest Sep 3, 2015
From: MAY, BRUCE CHANDLER
To: INFLAMMATORY RESPONSE RESEARCH, INC.
Reel/Frame 036487/0682 →
Assignment of Assignor's Interest Sep 3, 2015
From: MAY, BRUCE CHANDLER
To: INFLAMMATORY RESPONSE RESEARCH, INC.
Reel/Frame 036486/0837 →
Assignment of Assignor's Interest Sep 3, 2015
From: MAY, BRUCE CHANDLER
To: INFLAMMATORY RESPONSE RESEARCH, INC.
Reel/Frame 036486/0515 →